Clinical trial
Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer: Protocol for a Randomized Feasibility Trial
NCT07764341 is registered in ClinicalTrials.gov with King Hamad University Hospital, Bahrain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer: Protocol for a Randomized Feasibility Trial
- Lead sponsor
- King Hamad University Hospital, Bahrain
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- September 30, 2027
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer early stage breast cancer (stage 1-3), breast neoplasm malignant female